Third Quarter 2025 Results Revenue for the third quarter ended September 30, 2025, was $2.9 million, up 8% compared with $2.7 million of revenue for the same period last year. The primary reason for ...

By going with the 12-month package, you're going to see the best results when it comes to discounts, with the 4GB plan coming ...

Total revenues of $753,000 for third quarter, and $1,571,000 for first nine months of 2025, from sales and collaborative research agreement - - Major advances in pipeline as Humacyte moves closer to ...

Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported ...

Sick of pocket bricks? Meet the NanoPhone: the $89.97 game-changer that proves less is more. Grab it before it ...